At EMUC22, Dr. David D’Andrea (AT) shared the latest results from the multi-centre, open-label, phase 3 RCT: En-bloc vs conventional resection of primary bladder tumour (eBLOC).
For more detailed results of this study, watch also the webcast Dr. D’Andrea presented at EMUC22.